Observing outcomes of perilunate injuries in Canada
The Canadian Prospective Pragmatic Perilunate Outcomes Trial (The C3PO Trial)
This study is looking at how perilunate injuries are treated in Canada to see what happens to patients over time and improve care for these injuries.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 450 (estimated) |
| Ages | 14 Years to 120 Years |
| Sex | All |
| Sponsor | University of Calgary Academic / other |
| Locations | 1 site (Calgary, Alberta) |
| Trial ID | NCT04370626 on ClinicalTrials.gov |
What this trial studies
This observational study aims to collect and analyze data on perilunate injuries (PLIs) across Canada over a two to three-year period. It will include both prospective and retrospective data from various hospitals treating PLIs, focusing on injury and surgical parameters. The study will follow participants at scheduled intervals of two, five, and ten years to assess long-term outcomes and complications. The goal is to improve understanding of these complex injuries and their treatment outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 14 years or older who have been clinically diagnosed with a perilunate injury.
Not a fit: Patients who do not have a perilunate injury or are unwilling to adhere to the study protocol may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment protocols and better long-term outcomes for patients with perilunate injuries.
How similar studies have performed: While there is existing literature on perilunate injuries, this comprehensive observational approach is relatively novel and aims to fill gaps in understanding treatment variability and outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * The subject is 14 years of age or older * The subject has been clinically diagnosed with a perilunate injury * The subject is willing to adhere to the study protocol including required post-operative therapy, all scheduled follow-up visits, evaluations, and questionnaires (if applicable). Exclusion Criteria: There will be no limiting exclusion criteria.
Where this trial is running
Calgary, Alberta
- South Health Campus — Calgary, Alberta, Canada (Recruiting)
Study contacts
- Principal investigator: Neil J White, MD, FRCSC — University of Calgary
- Study coordinator: Adina Tarcea, BMSc
- Email: adina.tarcea@ucalgary.ca
- Phone: 4039563687
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.